Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2022 | 1 |
2023 | 3 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial.
JAMA Netw Open. 2023 Feb 1;6(2):e2255758. doi: 10.1001/jamanetworkopen.2022.55758.
JAMA Netw Open. 2023.
PMID: 36780159
Free PMC article.
Clinical Trial.
Prevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota-Based Therapeutic.
Berenson CS, Lashner B, Korman LY, Hohmann E, Deshpande A, Louie TJ, Sims M, Pardi D, Kraft CS, Wang EEL, Cohen SH, Feuerstadt P, Oneto C, Misra B, Pullman J, De A, Memisoglu A, Lombardi DA, Hasson BR, McGovern BH, von Moltke L, Lee CH.
Berenson CS, et al. Among authors: hasson br.
Clin Infect Dis. 2023 Nov 30;77(11):1504-1510. doi: 10.1093/cid/ciad448.
Clin Infect Dis. 2023.
PMID: 37539715
Free PMC article.
Clinical Trial.
Item in Clipboard
SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent Clostridioides difficile Infection (rCDI).
Khanna S, Sims M, Louie TJ, Fischer M, LaPlante K, Allegretti J, Hasson BR, Fonte AT, McChalicher C, Ege DS, Bryant JA, Straub TJ, Ford CB, Henn MR, Wang EEL, von Moltke L, Wilcox MH.
Khanna S, et al. Among authors: hasson br.
Antibiotics (Basel). 2022 Sep 10;11(9):1234. doi: 10.3390/antibiotics11091234.
Antibiotics (Basel). 2022.
PMID: 36140013
Free PMC article.
Review.
Item in Clipboard
Impact of a Purified Microbiome Therapeutic on Abundance of Antimicrobial Resistance Genes in Patients With Recurrent Clostridioides difficile Infection.
Straub TJ, Lombardo MJ, Bryant JA, Diao L, Lodise TP, Freedberg DE, Wortman JR, Litcofsky KD, Hasson BR, McGovern BH, Ford CB, Henn MR.
Straub TJ, et al. Among authors: hasson br.
Clin Infect Dis. 2024 Apr 10;78(4):833-841. doi: 10.1093/cid/ciad636.
Clin Infect Dis. 2024.
PMID: 37823484
Free PMC article.
Clinical Trial.
Item in Clipboard
Racial/Ethnic Differences in Insulin Resistance and Beta Cell Function: Relationship to Racial Disparities in Type 2 Diabetes among African Americans versus Caucasians.
Hasson BR, Apovian C, Istfan N.
Hasson BR, et al.
Curr Obes Rep. 2015 Jun;4(2):241-9. doi: 10.1007/s13679-015-0150-2.
Curr Obes Rep. 2015.
PMID: 26627219
Review.
Item in Clipboard
Manufacturing Processes of a Purified Microbiome Therapeutic Reduce Risk of Transmission of Potential Bacterial Pathogens in Donor Stool.
McChalicher CWJ, Lombardo MJ, Khanna S, McKenzie GJ, Halvorsen EM, Almomani S, Schuster B, Hasson BR, McGovern BH, Ege DS, Auniņš JG.
McChalicher CWJ, et al. Among authors: hasson br.
J Infect Dis. 2023 Nov 11;228(10):1452-1455. doi: 10.1093/infdis/jiad298.
J Infect Dis. 2023.
PMID: 37540090
Free PMC article.
Item in Clipboard
Cite
Cite